Recurrent Calcium Oxalate Kidney Stone Disease
1 clinical trials · Condition
◉ Watch Recurrent Calcium Oxalate Kidney Stone Disease
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels (NCT05161936) | Alnylam Pharmaceuticals | 2022-01-27 |
Track Recurrent Calcium Oxalate Kidney Stone Disease automatically
Every clearance here is in the API, with alerts when new ones post.